Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viral Transfer Technology
  • Published:

Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors

Gene Therapy volume 7, pages 1986–1992 (2000)Cite this article

Abstract

We have developed a micro-injection technique to deliver recombinant adenovirus and AAV to mouse fetuses at day 15 after conception. Several routes of delivery, including injections to the amniotic fluid, the front limb, the placenta, the liver, and the retro-orbital venus plexus, were tested using an E1-deleted recombinant adenovirus (Ad.CBlacZ) or a recombinant adeno-associated virus (AAV.CMVlacZ) carrying a β-galactosidase (lacZ) gene. Injection of Ad.CBlacZ into the amniotic cavity led to transgene expression in the skin and in the digestive tract of the fetuses. Injection of Ad.CBlacZ in the front limb resulted in LacZ expression in all major muscle groups around the injection site and at low levels in the liver. The other three routes of delivery, ie intra-placental, intra-hepatic and retro-orbital injections of Ad.CBlacZ, all led to lacZ expression predominantly in the liver. Further studies revealed a maximal tolerant dose (defined as the highest viral dose with ⩽20% mortality in the injected fetuses) of 1 × 109 particles per fetus for intra- hepatic injections, 3 × 109 particles per fetus for intra-placental injection, 1 × 1010 particles per fetus for retro-orbital and intra-amniotic injections, and 2 × 1010 particle per fetus for intra-muscular injection. The adenovirus-mediated lacZ expression in liver and muscle persisted for at least 6 weeks. Intra-muscular injection of AAV.CMVlacZ also resulted in lacZ expression in the muscle up to 3 months after birth with no indication of cellular immune response at the injection site. Taken together, our results demonstrated that prolonged transgene expression can be achieved by in utero gene transfer using either adenoviral or AAV vectors. The distribution of virus-mediated gene transfer appeared to determined mostly by the route of viral administration.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Pitt B et al. Retrovirus-mediated gene transfer in lungs of living fetal sheep Gene Therapy 1995 2: 344–350

    CAS  PubMed  Google Scholar 

  2. Turkay A, Saunders T, Kurachi K . Intrauterine gene transfer: gestational stage-specific gene delivery in mice Gene Therapy 1999 6: 1685–1694

    Article  CAS  PubMed  Google Scholar 

  3. Porada C et al. In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses Hum Gene Ther 1998 9: 1571–1585

    Article  CAS  PubMed  Google Scholar 

  4. Douar A, Themis M, Coutelle C . Fetal somatic gene therapy Mol Hum Reprod 1996 2: 633–641

    Article  CAS  PubMed  Google Scholar 

  5. Vincent M et al. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero Hum Gene Ther 1995 6: 1019–1028

    Article  CAS  PubMed  Google Scholar 

  6. McCray P et al. Adenoviral mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo J Clin Invest 1995 95: 2620–2632

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sekhon H, Larson J . In utero gene transfer into the pulmonary epithelium Nature Med 1995 1: 1201–1203

    Article  CAS  PubMed  Google Scholar 

  8. Holzinger A et al. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues Pediatr Res 1995 38: 844–850

    Article  CAS  PubMed  Google Scholar 

  9. Larson J et al. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero Lancet 1997 349: 619–620

    Article  CAS  PubMed  Google Scholar 

  10. Baldwin H, Mickanin C, Buck C . Adenovirus-mediated gene transfer during initial organogenesis in the mammalian embryo is promoter-dependent and tissue-specific Gene Therapy 1997 4: 1142–1149

    Article  CAS  PubMed  Google Scholar 

  11. Cohen J et al. Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model Mol Genet Metab 1998 64: 108–118

    Article  CAS  PubMed  Google Scholar 

  12. Wang G et al. Ultrasound-guided gene transfer to hepatocytes in utero Fetal Diagn Ther 1998 13: 197–205

    Article  PubMed  Google Scholar 

  13. Schachtner S et al. Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer Gene Therapy 1999 6: 1249–1257

    Article  CAS  PubMed  Google Scholar 

  14. Lipshutz G et al. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero Proc Natl Acad Sci USA 1999 96: 13324–13329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lipshutz G, Flebbe-Rehwaldt L, Gaensler K . Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero Surgery 1999 126: 171–177

    Article  CAS  PubMed  Google Scholar 

  16. Lipshut G, Flebbe-Rehwaldt L, Gaensler K . Adenovirus-mediated gene transfer in the midgestation fetal mouse J Surg Res 1999 84: 150–156

    Article  Google Scholar 

  17. Yang EY et al. Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus J Pediatr Surg 1999 34: 766–772

    Article  CAS  PubMed  Google Scholar 

  18. Muzyczka N . Use of adeno-associated virus as a general transduction vector for mammalian cells Curr Top Microbiol Immunol 1992 158: 97–127

    CAS  PubMed  Google Scholar 

  19. Kaufman M . The Atlas of Mouse Development Academic Press: San Diego, CA 1994

    Google Scholar 

  20. Solomon J . Ontogeny of defined immunity in mammals. In: Foetal and Neonatal Immunology. Neuberger A, Tatum E (eds) Elsevier: New York 1971 pp 234–306

  21. Xiao W et al. Adeno-associated virus as a vector for liver-directed gene therapy J Virol 1998 72: 10222–10226

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Kozarsky K, Grossman M, Wilson JM . Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia Somat Cell Mol Genet 1993 19: 449–458

    Article  CAS  PubMed  Google Scholar 

  23. Xiao WD et al. Gene therapy vectors based on adeno-associated virus type I J Virol 1999 73: 3994–4003

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the NICHD PO1-HD32649 (to MLB and XY).

Author information

Authors and Affiliations

  1. Department of Pediatrics, The George Washington University, Washington DC, USA

    ML Batshaw, K Newman & X Ye

  2. Centers for Genetic Medicine Research, Children's Research Institute, Children's National Medical Center, Washington DC, USA

    M Mitchell, M Jerebtsova, ML Batshaw & X Ye

Authors
  1. M Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Jerebtsova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. ML Batshaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Newman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. X Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitchell, M., Jerebtsova, M., Batshaw, M. et al. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Ther 7, 1986–1992 (2000). https://doi.org/10.1038/sj.gt.3301332

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301332

Keywords

This article is cited by

Search

Advanced search

Quick links